Logo Enovis

Enovis (ENOV) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Enovis · Health Care · ref. ETF XLV · 51 calls · price $24.83
💬JPI AI AssistantTry it →
What the company does: Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally.

📈 Enovis (ENOV) stock price

$24.83-18.8% over range
Aug 28, 25low $20.04 · high $33.32Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 5 analysts
📊 JPI status : Enovis has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 ENOV price target & analyst consensusprice $24.83

The price target · all analysts combined (5 targets)
Highest target · 1 firm of 5$45+81.2%
Median target · of 5 targets$39+57.1%
Lowest target · 1 firm of 5$29+16.8%
Current price$24.83
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 5100% $29 ↔ $45
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Enovis? The JPI assistant answers using our backtest data.

🏛️ Enovis insider buying: who's buying and how much › open the full page

1 insider bought4 buys / 6 mo $124k

🔎 Detailed analyses

✅ Historical analyst reliability on ENOV

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Baird  25% -9.7% 4
Canaccord Genuity  17% -12.3% 6
UBS  0% -17.0% 2
Wells Fargo  0% -17.2% 3
Evercore ISI Group  0% -20.4% 4
Needham  0% -26.0% 16
JMP Securities 0% -26.1% 2

📊 What $1,000 invested in Enovis would be worth › open the full page

In short — $1,000 invested in Enovis 10 years ago would be worth $613 today, i.e. -5%/yr on average. Best year: 2019 (+74%), worst: 2018 (-47%). Price performance, excluding dividends.

If I'd invested $1,000 in Enovis

InvestmentWorth todayGain
1 years ago$562-44%
3 years ago$461-54%
5 years ago$375-63%
→ See Enovis's full return history + gain calculator

Return by year (Enovis)

YearReturn$1,000 invested at year start
2026 (YTD)-7%$925 (-7%)
2025-39%$562 (-44%)
2024-22%$440 (-56%)
→ See Enovis's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Enovis

Loading news…

📋 All analyst calls on ENOV

▲ Buy · 🎯$45
Price at call : $24.74 — upside +82%
Today : $24.83 — upside +81%
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Aug 17, 27
Wells Fargo 
Aug 7, 26
▲ Overweight · 🎯$39
Price at call : $24.24 — upside +61%
Today : $24.83 — upside +57%
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 7, 27
BTIG 
Aug 6, 26
▲ Buy · 🎯$40
Price at call : $26.61 — upside +50%
Today : $24.83 — upside +61%
🎯 on ENOV : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Aug 6, 27
BMO Capital 
Jul 9, 26
▲ Outperform · 🎯$29
Price at call : $25.22 — upside +15%
Today : $24.83 — upside +17%
🎯 on ENOV : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Jul 9, 27
▲ Outperform · 🎯$32
Price at call : $25.52 — upside +25%
Today : $24.83 — upside +29%
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Jul 6, 27
BTIG 
May 22, 26
▲ Buy · 🎯$39
Price at call : $24.19 — upside +61%
Today : $24.83 — upside +57%
🎯 on ENOV : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : May 22, 27
▲ Outperform · 🎯$36
Price at call : $24.78 — upside +45%
Today : $24.83 — upside +45%
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : May 8, 27
Wells Fargo 
May 8, 26
▲ Overweight · 🎯$40
Price at call : $26.52 — upside +51%
Today : $24.83 — upside +61%
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 8, 27
See the other 43 calls, newest to oldest
▲ Outperform · 🎯$35
Price at call : $22.52 — upside +55%
Today : $24.83 — upside +41%
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Apr 6, 27
BTIG 
Feb 26, 26
▲ Buy · 🎯$43
Price at call : $25.47 — upside +69%
Today : $24.83 — upside +73%
🎯 on ENOV : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Feb 26, 27
Needham 
Feb 26, 26
▲ Buy · 🎯$52
Price at call : $25.42 — upside +105%
Today : $24.83 — upside +109%
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Feb 26, 27
BTIG 
Jan 6, 26
▲ Buy · 🎯$41
Price at call : $27.92 — upside +47%
Today : $24.83 — upside +65%
🎯 on ENOV : no call matured yet · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Jan 6, 27
▲ Buy · 🎯$50
Price at call : $27.32 — upside +83%
Today : $24.83 — upside +101%
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Dec 17, 26
▲ Buy · 🎯$45
Price at call : $27.36 — upside +64%
Today : $24.83 — upside +81%
🎯 on ENOV : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Dec 17, 26
Wells Fargo 
Nov 7, 25
▲ Overweight · 🎯$42
Price at call : $30.26 — upside +39%
Today : $24.83 — upside +69%
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 7, 26
▲ Buy · 🎯$58
Price at call : $28.11 — upside +106%
Today : $24.83 — upside +134%
Expected +106% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-13.8%
stock -14% · XLV +29%
matured Aug 8, 26
UBS 
Aug 8, 25
▲ Buy · 🎯$57
Price at call : $28.11 — upside +103%
Today : $24.83 — upside +130%
Expected +103% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
-13.8%
stock -14% · XLV +29%
matured Aug 8, 26
Wells Fargo 
Aug 8, 25
▲ Overweight · 🎯$41
Price at call : $28.11 — upside +46%
Today : $24.83 — upside +65%
Expected +46% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
-13.8%
stock -14% · XLV +29%
matured Aug 8, 26
Needham 
Aug 7, 25
▲ Buy · 🎯$49
Price at call : $28.52 — upside +72%
Today : $24.83 — upside +97%
Expected +72% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-6.7%
stock -7% · XLV +28%
matured Aug 7, 26
▲ Outperform · 🎯$46
Price at call : $34.74 — upside +32%
Today : $24.83 — upside +85%
Expected +32% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-32.0%
stock -32% · XLV +20%
matured Jul 8, 26
▲ Buy · 🎯$70
Price at call : $35.73 — upside +96%
Today : $24.83 — upside +182%
Expected +96% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-32.0%
stock -32% · XLV +11%
matured May 14, 26
▲ Market Outperform · 🎯$55
Price at call : $36.57 — upside +50%
Today : $24.83 — upside +122%
Expected +50% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 unranked overall
-32.2%
stock -32% · XLV +5%
matured May 9, 26
Needham 
May 9, 25
▲ Buy · 🎯$57
Price at call : $33.05 — upside +72%
Today : $24.83 — upside +130%
Expected +72% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-25.0%
stock -25% · XLV +8%
matured May 9, 26
Needham 
Apr 9, 25
▲ Buy · 🎯$64
Price at call : $34.22 — upside +87%
Today : $24.83 — upside +158%
Expected +87% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-29.9%
stock -30% · XLV +8%
matured Apr 9, 26
Needham 
Apr 2, 25
▲ Buy · 🎯$64
Price at call : $33.79 — upside +89%
Today : $24.83 — upside +158%
Expected +89% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-32.6%
stock -33% · XLV +2%
matured Apr 2, 26
Needham 
Feb 27, 25
▲ Buy · 🎯$64
Price at call : $38.12 — upside +68%
Today : $24.83 — upside +158%
Expected +68% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-33.2%
stock -33% · XLV +9%
matured Feb 27, 26
Needham 
Nov 7, 24
▲ Buy · 🎯$65
Price at call : $47.86 — upside +36%
Today : $24.83 — upside +162%
Expected +36% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-41.4%
stock -41% · XLV -2%
matured Nov 7, 25
▲ Market Outperform · 🎯$62
Price at call : $39.96 — upside +55%
Today : $24.83 — upside +150%
Expected +55% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 unranked overall
-19.9%
stock -20% · XLV -4%
matured Oct 3, 25
▲ Outperform · 🎯$58
Price at call : $40.84 — upside +42%
Today : $24.83 — upside +134%
Expected +42% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-25.2%
stock -25% · XLV -6%
matured Oct 1, 25
JP Morgan 
Aug 8, 24
■ Neutral neutral · not a buy · 🎯$50
Price at call : $43.4 — gap to target +15%
Today : $24.83 — gap to target +101%
🎯 on ENOV : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Aug 8, 25
Needham 
Aug 8, 24
▲ Buy · 🎯$65
Price at call : $43.56 — upside +49%
Today : $24.83 — upside +162%
Expected +49% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-34.7%
stock -35% · XLV -13%
matured Aug 8, 25
▲ Outperform · 🎯$62
Price at call : $44.44 — upside +40%
Today : $24.83 — upside +150%
Expected +40% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-24.3%
stock -24% · XLV -5%
matured Jul 2, 25
JP Morgan 
Jun 13, 24
■ Neutral neutral · not a buy · 🎯$53
Price at call : $44.84 — gap to target +18%
Today : $24.83 — gap to target +113%
🎯 on ENOV : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Jun 13, 25
Needham 
May 3, 24
▲ Buy · 🎯$82
Price at call : $51.27 — upside +60%
Today : $24.83 — upside +230%
Expected +60% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-33.4%
stock -33% · XLV -2%
matured May 3, 25
Needham 
Apr 10, 24
▲ Buy · 🎯$82
Price at call : $59.95 — upside +37%
Today : $24.83 — upside +230%
Expected +37% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-46.5%
stock -46% · XLV -5%
matured Apr 10, 25
Wells Fargo 
Feb 23, 24
▲ Overweight · 🎯$79
Price at call : $61.56 — upside +28%
Today : $24.83 — upside +218%
Expected +28% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
-29.3%
stock -29% · XLV +0%
matured Feb 22, 25
▲ Buy · 🎯$75
Price at call : $61.56 — upside +22%
Today : $24.83 — upside +202%
Expected +22% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-29.3%
stock -29% · XLV +0%
matured Feb 22, 25
Needham 
Feb 23, 24
▲ Buy · 🎯$82
Price at call : $62.85 — upside +30%
Today : $24.83 — upside +230%
Expected +30% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-30.7%
stock -31% · XLV -0%
matured Feb 22, 25
Stephens & Co. 
Feb 13, 24
▲ Overweight · 🎯$72
Price at call : $59.76 — upside +20%
Today : $24.83 — upside +190%
Expected +20% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (1 call matured) · 📊 on Health : 46.4% · +3.2% (84 calls)
-26.6%
stock -27% · XLV +2%
matured Feb 12, 25
UBS 
Jan 22, 24
▲ Buy · 🎯$75
Price at call : $60.21 — upside +25%
Today : $24.83 — upside +202%
Expected +25% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 50% · +2.7% (74 calls)
-20.3%
stock -20% · XLV +2%
matured Jan 21, 25
Needham 
Jan 8, 24
▲ Buy · 🎯$73
Price at call : $57.33 — upside +27%
Today : $24.83 — upside +194%
Expected +27% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-21.9%
stock -22% · XLV -0%
matured Jan 7, 25
William Blair 
Jan 3, 24
▲ Outperform
Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)
-22.0%
stock -22% · XLV -0%
matured Jan 2, 25
▲ Buy · 🎯$71
Price at call : $54.96 — upside +29%
Today : $24.83 — upside +186%
Expected +29% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-22.7%
stock -23% · XLV +3%
matured Dec 19, 24
Needham 
Dec 15, 23
▲ Buy · 🎯$70
Price at call : $53.62 — upside +31%
Today : $24.83 — upside +182%
Expected +31% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-14.6%
stock -15% · XLV +4%
matured Dec 14, 24
Needham 
Nov 8, 23
▲ Buy · 🎯$62
Price at call : $48.22 — upside +29%
Today : $24.83 — upside +150%
Expected +29% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-0.8%
stock -1% · XLV +16%
matured Nov 7, 24
Roth MKM
Oct 20, 23
▲ Buy · 🎯$75
Price at call : $44.47 — upside +69%
Today : $24.83 — upside +202%
Expected +69% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (1 call matured) · 📊 unranked overall
-8.9%
stock -9% · XLV +18%
matured Oct 19, 24
Needham 
Oct 20, 23
▲ Buy · 🎯$70
Price at call : $44.47 — upside +57%
Today : $24.83 — upside +182%
Expected +57% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-8.9%
stock -9% · XLV +18%
matured Oct 19, 24
Baird 
Aug 4, 23
▲ Outperform · 🎯$70
Price at call : $59.23 — upside +18%
Today : $24.83 — upside +182%
Expected +18% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (1 call matured) · 📊 on Health : 37.8% · -2.8% (82 calls)
-29.6%
stock -30% · XLV +11%
matured Aug 3, 24
Needham 
Aug 4, 23
▲ Buy · 🎯$70
Price at call : $59.23 — upside +18%
Today : $24.83 — upside +182%
Expected +18% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-29.6%
stock -30% · XLV +11%
matured Aug 3, 24
Needham 
Jun 26, 23
▲ Buy · 🎯$70
Price at call : $61.5 — upside +14%
Today : $24.83 — upside +182%
Expected +14% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (16 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-26.8%
stock -27% · XLV +12%
matured Jun 25, 24
Argus Research 
Jun 28, 22
■ Hold neutral · not a buy
🎯 on ENOV : no call matured yet · 📊 on Health : 18.2% · -27.9% (11 calls)
in progress (365j)
matures : Jun 28, 23

Frequently asked questions

Should I buy Enovis stock?

This isn't buy advice. For Enovis, the analyst consensus is "Buy", with an average price target of $39.00 (+57% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 25% of the time (4 calls tracked on Enovis). We show the numbers — you decide.

Is it too late to buy Enovis? How high can it go?

The most bullish analyst target on Enovis is $45.00 (+81% above today's price); the average is $39.00. That's the upside they see. Check how reliable those analysts have actually been on Enovis on our site before trusting it.

Is Enovis still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 7 analysts have a real record on Enovis, the best hitting 25% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in Enovis? The case for and against

The arguments for and against, one by one, from the numbers: why invest in ENOV (and why hesitate).

What has Enovis's past performance been?

Historical returns and a "how much if I had invested" calculator: ENOV performance & returns.

Are insiders buying ENOV stock?

Executives' and large holders' buys and sells, decoded: insider buying on ENOV.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)